Señales en vivo de PLXP | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (12 abr 2023 @ 16:00):

Stats
Volumen de hoy	50.38M
Volumen promedio	4.86M
Capitalización de mercado	2.53M
EPS	$0 ( 2023-11-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.223
ATR14	$0.0270 (469.57%)

Insider Trading

Date	Person	Action	Amount	type
2022-03-15	Giordano Natasha	Buy	4 100	Common Stock
2022-03-15	O'connor Rita M	Buy	3 700	Common Stock
2022-03-15	O'connor Rita M	Buy	10 000	Common Stock
2022-02-22	Valentino Michael J	Buy	80 000	Stock Option (right to buy)
2022-02-22	O'connor Rita M	Buy	110 000	Stock Option (right to buy)

INSIDER POWER
0.00
Last 94 transactions
Buy: 5 718 001 \| Sell: 1 856 163

Volumen Correlación

Largo: 0.18 (neutral)

Corto: -0.79 (moderate negative)

Signal:(38.252) Neutral

PLx Pharma Inc Correlación

10 Correlaciones Más Positivas
ONCS	0.955
WISA	0.952
INSG	0.947
IMRX	0.943
PRTK	0.943
INVE	0.943
TOI	0.942
VERV	0.938
TIL	0.937
TFFP	0.935

10 Correlaciones Más Negativas
AGFS	-0.912
CCRC	-0.91
LRFC	-0.907
MNKD	-0.903
IBEX	-0.901
STAY	-0.896
LWAC	-0.894
NWFL	-0.892
HZNP	-0.889
SLGN	-0.887

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PLx Pharma Inc Correlación - Moneda/Commodity

-0.76
( moderate negative )

-0.71
( moderate negative )

0.00
( neutral )

-0.65
( weak negative )

-0.30
( neutral )

0.40
( neutral )

PLx Pharma Inc Finanzas

Annual	2021
Ingresos:	$8.21M
Beneficio Bruto:	$3.40M (41.46 %)
EPS:	$-1.714

FY	2021
Ingresos:	$8.21M
Beneficio Bruto:	$3.40M (41.46 %)
EPS:	$-1.714

FY	2020
Ingresos:	$30 430.00
Beneficio Bruto:	$30.43 (0.10 %)
EPS:	$-1.740

FY	2019
Ingresos:	$565 464
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-2.30

Financial Reports:

No articles found.

PLx Pharma Inc

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.